A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic Transplantation

FLT3-ITD-mutated acute myeloid leukemia (AML) remains a therapeutic challenge. FLT3 inhibition in the setting of minimal residual disease and a new immune system via allogeneic transplantation offers a promise of improved survival for these patients. We performed a prospective study of patients with...

詳細記述

保存先:
書誌詳細
出版年:Biol Blood Marrow Transplant
主要な著者: Pratz, Keith W., Rudek, Michelle A., Smith, B. Douglas, Karp, Judith, Gojo, Ivana, Dezern, Amy, Jones, Richard J., Greer, Jackie, Gocke, Christopher, Baer, Maria R., Duong, Vu H., Rosner, Gary, Zahurak, Marianna, Wright, John J., Emadi, Ashkan, Levis, Mark
フォーマット: Artigo
言語:Inglês
出版事項: 2019
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7001148/
https://ncbi.nlm.nih.gov/pubmed/31550496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2019.09.023
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料